Kao Yung-Shuo, Yeh Cheng-Chang, Chen Yi-Fang
Dr Kao Clinic, Taichung 406, Taiwan.
Department of Oral Hygiene Care, Ching-Kuo Institute of Management and Health, Keelung 203, Taiwan.
Cancers (Basel). 2023 Jan 19;15(3):640. doi: 10.3390/cancers15030640.
The risk of cancer and dementia increases with age, raising complex questions about whether it is appropriate to continue cancer treatment in older patients. There is emerging research suggesting the association between cancer and dementia. However, the mechanistic underpinnings are still under investigation. Progress has already been made toward understanding the cognitive effects associated with cancer therapy. Such associations raise awareness about the need to establish better prevention methods and early screening in clinical practice. Additionally, recent studies have suggested possible therapeutic strategies for better preserving cognitive function and reducing the risk for dementia before patients start cancer treatment. We review the current literature and summarize the incidence and mechanisms of cognitive impairment in patients with lung cancer, breast cancer, head and neck cancer, gastric cancer, prostate cancer, colorectal cancer, and brain tumor/brain metastasis following different kinds of therapies. Possible risk factors are suggested to identify the early onset of cognitive changes in cancer patients and provide more insight into the pathophysiological process of dementia.
癌症和痴呆症的风险会随着年龄增长而增加,这引发了关于老年患者是否适合继续接受癌症治疗的复杂问题。有新出现的研究表明癌症与痴呆症之间存在关联。然而,其机制基础仍在研究之中。在理解与癌症治疗相关的认知影响方面已经取得了进展。这些关联提高了人们对在临床实践中建立更好的预防方法和早期筛查必要性的认识。此外,最近的研究提出了一些可能的治疗策略,以便在患者开始癌症治疗前更好地保护认知功能并降低患痴呆症的风险。我们回顾了当前的文献,并总结了肺癌、乳腺癌、头颈癌、胃癌、前列腺癌、结直肠癌以及脑肿瘤/脑转移患者在接受不同类型治疗后认知障碍的发生率和机制。建议通过可能的风险因素来识别癌症患者认知变化的早期发作,并更深入地了解痴呆症的病理生理过程。